TerrAscend provides quality products, brands, and services to the global cannabinoid market. As the first North American Operator, with scale operations in both Canada and the US, the Company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use. Additionally, TerrAscend will soon be the first and only cannabis company with sales in the US, Canada, and Europe as it has received EU GMP certification for its manufacturing facility in Mississauga, Ontario. TerrAscend operates a number of synergistic businesses, including Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company committed to the continuous improvement of cannabinoid expressing plants; and Solace RX Inc., a proposed Drug Preparation Premises focused on the development of novel formulations and delivery forms.
TerrAscend Corp. (TER)
May 2, 2017
The common shares of TerrAscend Corp. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com
TerrAscend is a vertically integrated company that is focused on the production, sale and distribution of cannabis and its derivatives for the medical market. TerrAscend’s wholly-owned subsidiary, Solace Health Inc., is in the final stage of its application for licencing under the Access to Cannabis for Medical Purposes Regulations.